Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18582837 | POLYMERIC DISPERSANTS FROM PHENYL GLYCIDYL ETHER | February 2024 | April 2025 | Allow | 14 | 1 | 1 | Yes | No |
| 18423852 | MULTI-LAYER HAEMOSTAT PATCH COMPRISING BETA-CHITIN | January 2024 | June 2025 | Abandon | 16 | 1 | 1 | No | No |
| 18470327 | ENCAPSULATION OF GASTRIC RESIDENCE SYSTEMS | September 2023 | December 2024 | Allow | 14 | 2 | 0 | Yes | No |
| 18464906 | MAKEUP COMPOSITIONS FOR TREATING SKIN DEFECTS | September 2023 | March 2025 | Abandon | 18 | 0 | 1 | No | No |
| 18242468 | CARBOHYDRATE CROSSLINKER | September 2023 | April 2025 | Abandon | 20 | 3 | 0 | Yes | No |
| 18230438 | INHALATION OF NITRIC OXIDE FOR TREATING RESPIRATORY DISEASES | August 2023 | March 2025 | Abandon | 19 | 1 | 0 | No | No |
| 18365074 | RINSE-OFF COMPOSITIONS AND USES THEREOF FOR DELIVERY OF ACTIVE AGENTS | August 2023 | May 2025 | Abandon | 22 | 1 | 0 | No | No |
| 18346895 | STERILIZATION OF SELF-ASSEMBLING PEPTIDES BY IRRADIATION | July 2023 | May 2024 | Allow | 10 | 1 | 1 | Yes | No |
| 18256582 | DIFFUSER OF VOLATILE LIQUID SUBSTANCES EQUIPPED WITH A VAPOR PERMEABLE MEMBRANE, ACTIVATED AT THE TIME OF USE | June 2023 | February 2024 | Allow | 8 | 1 | 0 | No | No |
| 18198684 | SELF-PRESERVING TOPICAL PHARMACEUTICAL COMPOSITIONS COMPRISING DIETHYLENE GLYCOL MONOETHYL ETHER | May 2023 | February 2026 | Abandon | 33 | 5 | 0 | Yes | No |
| 18143368 | ALBUMIN-BASED NON-COVALENT COMPLEXES AND METHODS OF USE THEREOF | May 2023 | March 2025 | Allow | 22 | 2 | 0 | No | No |
| 18300281 | LONG ACTING, CONTINUOUS ORAL RELEASE FROM ORAL DISPERSING STRIPS (ODS) ADDRESSING THE NEED FOR HIGH DOSAGE OF ACTIVE INGREDIENTS | April 2023 | January 2025 | Abandon | 21 | 3 | 1 | Yes | No |
| 18185099 | PROCESS FOR THE PREPARATION OF A COMPOSITION OF LIPOAMINO ACIDS AND DIOLS | March 2023 | March 2025 | Abandon | 25 | 2 | 0 | No | No |
| 18184439 | CARBOHYDRATE CROSSLINKER | March 2023 | June 2023 | Allow | 3 | 1 | 0 | No | No |
| 18115511 | COMPOSITE TUBULAR MATERIAL PREPARED FROM EXTRACELLULAR MATRIX AND SYNTHETIC POLYMER, AND PREPARATION METHOD THEREOF | February 2023 | July 2024 | Allow | 17 | 2 | 1 | Yes | No |
| 18098239 | method for treating deep wounds of dermis and/or below tissue | January 2023 | October 2024 | Abandon | 21 | 4 | 0 | Yes | No |
| 18074244 | STERILIZATION OF SELF-ASSEMBLING PEPTIDES BY IRRADIATION | December 2022 | April 2023 | Allow | 4 | 1 | 0 | No | No |
| 18071282 | CARBOHYDRATE CROSSLINKER | November 2022 | February 2023 | Allow | 3 | 1 | 0 | No | No |
| 18056310 | METHOD FOR TERMINATING CANCER CELLS WITH AN AZOLE-BASED COMPOUND | November 2022 | June 2023 | Allow | 7 | 2 | 0 | Yes | No |
| 17983330 | Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same | November 2022 | September 2023 | Abandon | 10 | 1 | 0 | No | No |
| 17981445 | STERILIZATION OF SELF-ASSEMBLING PEPTIDES BY IRRADIATION | November 2022 | April 2023 | Allow | 5 | 1 | 0 | Yes | No |
| 18048707 | MOULDED ARTICLE FOR COMBATING VARROA MITES | October 2022 | September 2025 | Abandon | 35 | 2 | 1 | No | Yes |
| 18048423 | HYBRID CARRIERS FOR NUCLEIC ACID CARGO | October 2022 | January 2024 | Abandon | 15 | 0 | 1 | No | No |
| 17935300 | PROMOTING ENDOTHELIAL CELL AFFINITY AND ANTITHROMBOGENICITY OF POLYTETRAFLUOROETHYLENE (PTFE) BY MUSSEL-INSPIRED MODIFICATION AND RGD/HEPARIN GRAFTING | September 2022 | June 2023 | Allow | 8 | 1 | 0 | Yes | No |
| 17770173 | Microbial Compositions For Preserving Healthy Soils And Restoring Degraded Soils | September 2022 | October 2025 | Abandon | 42 | 0 | 1 | No | No |
| 17877905 | Microbe-Based Products for Enhancing Plant Root and Immune Health | July 2022 | March 2026 | Allow | 43 | 3 | 1 | Yes | No |
| 17796149 | AGROCHEMICAL COMPOSITION OF TRIAZOLES | July 2022 | October 2025 | Allow | 39 | 4 | 1 | Yes | Yes |
| 17863642 | TEAR FILM STABILITY | July 2022 | July 2025 | Abandon | 36 | 4 | 0 | No | No |
| 17856198 | LUBRICATING BLOCK COPOLYMERS AND THEIR USE AS BIOMIMETIC BOUNDARY LUBRICANTS | July 2022 | March 2025 | Allow | 32 | 2 | 1 | Yes | No |
| 17845141 | SETTABLE BONE VOID FILLER | June 2022 | October 2024 | Allow | 28 | 2 | 0 | Yes | No |
| 17831392 | ELECTROACTIVE BIOADHESIVE COMPOSITIONS | June 2022 | December 2023 | Allow | 18 | 1 | 0 | No | No |
| 17662923 | FUNCTIONAL MICROSCAFFOLD THAT CAN BE MAGNETICALLY ACTUATED AND MANUFACTURING METHOD THEREFOR | May 2022 | June 2025 | Abandon | 37 | 1 | 0 | No | No |
| 17740192 | OPHTHALMIC DRUG SUSTAINED RELEASE FORMULATION AND USES THEREOF | May 2022 | December 2023 | Allow | 19 | 2 | 0 | No | No |
| 17775372 | METABOLITE-BASED POLYMERS AND MICROPARTICLES FOR DELIVERY OF THERAPEUTIC AGENTS AND TISSUE REGENERATION | May 2022 | November 2025 | Abandon | 43 | 5 | 1 | Yes | No |
| 17774103 | COMBINED PREPARATION AND METHOD FOR COMBATING FUNGUS-GROWING ANTS | May 2022 | May 2025 | Abandon | 37 | 0 | 1 | No | No |
| 17754886 | BIOSOURCED GELLING POLYAMIDES | April 2022 | December 2025 | Allow | 44 | 1 | 1 | Yes | No |
| 17658663 | UNIVERSAL PHOTODYNAMIC SPRAY COATINGS FOR INFECTION CONTROL | April 2022 | October 2025 | Allow | 42 | 2 | 0 | Yes | No |
| 17717837 | METHOD FOR FORMING ELASTIC FILM STRETCHABLE STRUCTURE AND ABSORBENT ARTICLE | April 2022 | March 2024 | Allow | 24 | 0 | 0 | No | No |
| 17718169 | HYDROPHILIC MEDICAL PRODUCTS AND HYDRATION MEDIUMS FOR HYDRATING THE SAME | April 2022 | January 2025 | Allow | 33 | 2 | 0 | No | No |
| 17762889 | ACTIVE COMPOUND COMBINATIONS COMPRISING FATTY ACIDS | March 2022 | May 2025 | Abandon | 38 | 1 | 0 | No | No |
| 17640707 | FAST CONSOLIDATING COMPOUNDS | March 2022 | November 2025 | Abandon | 44 | 1 | 1 | No | No |
| 17639374 | POLYMERS FOR SPRAY DRIFT CONTROL OF PESTICIDE SPRAY | March 2022 | December 2025 | Abandon | 45 | 2 | 1 | No | No |
| 17638989 | METHOD FOR CONTROLLING GROWTH OF GLYPHOSATE-TOLERANT PLANTS | February 2022 | June 2025 | Abandon | 40 | 1 | 0 | No | No |
| 17633050 | MOLECULAR COMPLEXES | February 2022 | May 2025 | Abandon | 40 | 1 | 0 | No | No |
| 17622384 | NANOVESICLES | December 2021 | July 2025 | Abandon | 43 | 0 | 1 | No | No |
| 17554720 | ORGANIC SOLVENT FREE COMPOSITIONS COMPRISING PROTEIN-POLYMER CONJUGATES AND USES THEREOF | December 2021 | July 2025 | Allow | 43 | 2 | 0 | Yes | No |
| 17524801 | SELF-REINFORCED STARCH-BASED MULTIFUNCTIONAL MATERIALS AND PROCESSING METHOD THEREOF | November 2021 | May 2022 | Allow | 6 | 1 | 1 | Yes | No |
| 17520987 | Devices and Methods for Nerve Regeneration | November 2021 | March 2023 | Allow | 16 | 1 | 0 | No | No |
| 17519368 | Microgel Compositions | November 2021 | March 2025 | Abandon | 40 | 2 | 1 | No | No |
| 17518124 | BIOLOGICAL MATERIAL WITH COMPOSITE EXTRACELLULAR MATRIX COMPONENTS | November 2021 | July 2025 | Abandon | 45 | 2 | 0 | No | No |
| 17470121 | TECHNIQUES FOR ENHANCING THE SELECTIVITY AND EFFICACY OF ANTIMICROBIAL AND ANTICANCER POLYMER AGENTS | September 2021 | December 2025 | Allow | 51 | 2 | 1 | Yes | No |
| 17460190 | METHOD OF DESIGNING FILM-FORMING AGENT OR COSMETIC CONTAINING THE SAME | August 2021 | February 2026 | Abandon | 53 | 4 | 0 | No | No |
| 17412241 | INHALATION OF NITRIC OXIDE FOR TREATING RESPIRATORY DISEASES | August 2021 | October 2025 | Allow | 50 | 2 | 0 | Yes | Yes |
| 17423716 | SYNERGISTIC HERBICIDAL MIXTURES AND COMPOSITIONS COMPRISING TRICLOPYR AND PHOSPHATE ESTER ADJUVANTS | July 2021 | July 2025 | Allow | 48 | 2 | 1 | Yes | No |
| 17377124 | MODIFIED ALGINATES FOR ANTI-FIBROTIC MATERIALS AND APPLICATIONS | July 2021 | May 2024 | Allow | 34 | 2 | 0 | No | No |
| 17417628 | METHOD FOR CONTROLLING WEED | June 2021 | February 2025 | Abandon | 44 | 1 | 0 | No | No |
| 17303630 | METHOD OF LONG-TERM PRESERVATION OF CHEMICAL AND BIOLOGICAL SPECIES USING SUGAR GLASSES | June 2021 | April 2025 | Abandon | 47 | 6 | 0 | No | No |
| 17335643 | POLYMERS WITH ANTIMICROBIAL FUNCTIONALITIES | June 2021 | March 2023 | Allow | 22 | 1 | 0 | Yes | No |
| 17334350 | NERVE REGENERATION-INDUCING MATERIAL | May 2021 | November 2025 | Abandon | 54 | 4 | 0 | Yes | No |
| 17296429 | COSMETIC COMPOSITION COMPRISING SPECIFIC HYPERBRANCHED COPOLYMERS AND LIQUID DISPERSIONS OF AN ACRYLIC POLYMER | May 2021 | September 2025 | Abandon | 52 | 2 | 0 | No | Yes |
| 17296471 | COSMETIC COMPOSITION COMPRISING SPECIFIC HYPERBRANCHED COPOLYMERS AND OILS | May 2021 | September 2025 | Abandon | 52 | 2 | 0 | Yes | Yes |
| 17296260 | METHOD FOR MANUFACTURING RED BLOOD CELL-SHAPED NANOSTRUCTURE USING MULTI-FLUID ELECTROSPRAY METHOD INCLUDING MULTIPLE NOZZLES | May 2021 | November 2025 | Abandon | 54 | 3 | 1 | No | No |
| 17294751 | SYNERGISTIC HERBICIDE COMPOSITION OF BROAD-SPECTRUM FOR THE CONTROL OF WEEDS IN AGRICULTURAL CULTURES, USE OF SUCH COMPOSITION FOR PREPARATION OF PRODUCT, PRODUCT AND METHOD OF APPLICATION | May 2021 | December 2023 | Allow | 31 | 3 | 1 | Yes | No |
| 17323627 | CROSSLINKED CATION EXCHANGE POLYMERS, COMPOSITIONS AND USE IN TREATING HYPERKALEMIA | May 2021 | March 2026 | Abandon | 58 | 5 | 0 | No | Yes |
| 17315476 | Pesticidal Compositions and Related Methods | May 2021 | July 2022 | Allow | 14 | 2 | 1 | Yes | No |
| 17292151 | Water Soluble Silicon-Containing Granulate | May 2021 | December 2025 | Allow | 55 | 3 | 1 | Yes | No |
| 17291992 | Compositions and Methods for Modulating Root Growth | May 2021 | August 2024 | Allow | 39 | 2 | 1 | Yes | No |
| 17308139 | METHOD FOR MAKING A CONJUGATE AZOLE-BASED SURFACE MODIFIED SILICON DIOXIDE NANOPARTICLE | May 2021 | November 2022 | Allow | 18 | 1 | 0 | No | No |
| 17291107 | COMPOSITIONS COMPRISING PYRIDINE CARBOXYLATE HERBICIDES AND AZOLE CARBOXYLATE SAFENERS | May 2021 | May 2025 | Allow | 48 | 4 | 1 | Yes | No |
| 17306456 | ANTIMICROBIAL COATING COMPOSITIONS | May 2021 | July 2023 | Abandon | 26 | 1 | 0 | No | No |
| 17245165 | Methods For Killing Insects Such As Drosophila species | April 2021 | September 2025 | Abandon | 52 | 4 | 0 | No | Yes |
| 17290556 | PESTICIDALLY ACTIVE AZOLE-AMIDE COMPOUNDS | April 2021 | July 2024 | Allow | 38 | 1 | 0 | No | No |
| 17290232 | COMPOSITIONS COMPRISING HALAUXIFEN AND OTHER HERBICIDES AND METHODS THEREOF | April 2021 | November 2024 | Abandon | 42 | 1 | 1 | No | No |
| 17285321 | Treatment of Plants or Fungi Against Disease | April 2021 | June 2024 | Abandon | 38 | 1 | 0 | No | No |
| 17229004 | METHOD FOR MANUFACTURING MEDICAL SPONGE FOR ORTHOPEDIC TREATMENT BY UNILATERAL PRESSING | April 2021 | August 2021 | Allow | 4 | 1 | 0 | No | No |
| 17284804 | HERBICIDE COMPOSITION | April 2021 | December 2025 | Abandon | 56 | 3 | 1 | No | No |
| 17222453 | LINEAR POLYOL STABILIZED POLYFLUOROACRYLATE COMPOSITIONS | April 2021 | April 2023 | Abandon | 24 | 1 | 0 | No | No |
| 17218775 | ANTIMICROBIAL POLYCARBONATES FOR MULTIDRUG RESISTANT BACTERIA | March 2021 | January 2026 | Abandon | 57 | 4 | 1 | Yes | No |
| 17217911 | STERILIZATION OF SELF-ASSEMBLING PEPTIDES BY IRRADIATION | March 2021 | September 2022 | Allow | 18 | 2 | 1 | Yes | No |
| 17215700 | ANTIMICROBIAL POLYMERS CAPABLE OF SUPRAMOLECULAR ASSEMBLY | March 2021 | January 2023 | Allow | 21 | 1 | 0 | Yes | No |
| 17214788 | METHOD OF PREVENTING MICROBES IN DISPOSABLE PRODUCTS | March 2021 | February 2024 | Abandon | 34 | 0 | 1 | Yes | No |
| 17204093 | Tissue-Adhesive Material | March 2021 | June 2023 | Allow | 27 | 2 | 0 | Yes | No |
| 17204679 | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MEDIATED DISEASES | March 2021 | November 2023 | Allow | 32 | 2 | 0 | Yes | No |
| 17276616 | Use of the Succinate Dehydrogenase Inhibitor Fluopyram for Controlling Claviceps Purpurea and Reducing Sclerotia in Cereals | March 2021 | December 2025 | Abandon | 57 | 5 | 0 | No | No |
| 17276315 | PHARMACEUTICAL COMPOSITION FOR TOPICAL USE COMPRISING AT LEAST ONE LOCAL ANAESTHETIC SUBSTANCE | March 2021 | September 2025 | Abandon | 54 | 2 | 1 | No | No |
| 17188820 | MAKEUP COMPOSITIONS FOR TREATING SKIN DEFECTS | March 2021 | September 2023 | Abandon | 31 | 0 | 1 | No | No |
| 17184152 | NON-LINEAR MULTIBLOCK COPOLYMER-DRUG CONJUGATES FOR THE DELIVERY OF ACTIVE AGENTS | February 2021 | January 2023 | Allow | 23 | 1 | 0 | No | No |
| 17270721 | COMPOSITION FOR COATING AND ENCRUSTING INDUSTRIAL OR NON-INDUSTRIAL SEEDS FOR BIOLOGICAL CONTROL OF PHYTONEMATODE AND PHYTOPATHOGENIC SPECIES | February 2021 | September 2024 | Abandon | 43 | 2 | 0 | No | No |
| 17168998 | RINSE-OFF COMPOSITIONS AND USES THEREOF FOR DELIVERY OF ACTIVE AGENTS | February 2021 | January 2024 | Abandon | 35 | 2 | 0 | No | No |
| 17265297 | DISPOSABLE WEARABLE ABSORBENT ARTICLE | February 2021 | October 2021 | Allow | 9 | 0 | 1 | No | No |
| 17248501 | METHOD OF TREATING A VIRAL INFECTION | January 2021 | July 2023 | Abandon | 30 | 4 | 0 | No | No |
| 17262790 | METHOD FOR PATHOGENS, MICROORGANISMS, AND PARASITES INACTIVATION | January 2021 | June 2024 | Abandon | 41 | 1 | 0 | No | No |
| 17154251 | ALBUMIN-BASED NON-COVALENT COMPLEXES AND METHODS OF USE THEREOF | January 2021 | May 2023 | Abandon | 28 | 1 | 0 | No | No |
| 17260724 | COSMETIC COMPOSITION FOR INCREASING SKIN EXFOLIATION | January 2021 | August 2024 | Abandon | 43 | 2 | 0 | Yes | No |
| 17136709 | UTILIZING POLYMERS AND ANTIBIOTICS TO ENHANCE ANTIMICROBIAL ACTIVITY AND INHIBIT ANTIBIOTIC RESISTANCE | December 2020 | July 2023 | Allow | 31 | 1 | 0 | Yes | No |
| 17256354 | THERAPEUTIC HYDROGELS AND CONTACT LENS FOR CORNEAL MELTING | December 2020 | January 2024 | Allow | 36 | 1 | 0 | Yes | No |
| 17251897 | METHOD OF IMPROVING HEALTH AND ROOTING OF HARDWOOD TREES | December 2020 | September 2024 | Abandon | 45 | 2 | 0 | No | No |
| 17113607 | Methods and Compositions for Administering an Active Agent to the Pleura of a Patient | December 2020 | March 2026 | Abandon | 60 | 6 | 0 | No | No |
| 17058368 | BIFUNCTIONAL MODIFIED BIOPOLYMER BASED POLYMERS AND HYDROGELS OBTAINABLE FROM SUCH BIFUNCTIONAL MODIFIED BIOPOLYMER BASED POLYMERS | November 2020 | June 2025 | Abandon | 55 | 4 | 1 | No | No |
| 17102109 | CANNABINOIDS IN COMBINATION WITH NON-CANNABINOID CHEMOTHERAPEUTIC AGENTS | November 2020 | April 2025 | Abandon | 53 | 4 | 0 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner PIPIC, ALMA.
With a 20.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 16.9% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner PIPIC, ALMA works in Art Unit 1617 and has examined 708 patent applications in our dataset. With an allowance rate of 55.5%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 34 months.
Examiner PIPIC, ALMA's allowance rate of 55.5% places them in the 16% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by PIPIC, ALMA receive 2.60 office actions before reaching final disposition. This places the examiner in the 76% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by PIPIC, ALMA is 34 months. This places the examiner in the 42% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +60.9% benefit to allowance rate for applications examined by PIPIC, ALMA. This interview benefit is in the 97% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 15.2% of applications are subsequently allowed. This success rate is in the 11% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 30.3% of cases where such amendments are filed. This entry rate is in the 44% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.
When applicants request a pre-appeal conference (PAC) with this examiner, 21.1% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 27% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.
This examiner withdraws rejections or reopens prosecution in 55.4% of appeals filed. This is in the 27% percentile among all examiners. Of these withdrawals, 45.2% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.
When applicants file petitions regarding this examiner's actions, 50.5% are granted (fully or in part). This grant rate is in the 49% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 0% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 0% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.